Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
AI-powered market analysis and insights
Surgery Partners is rumored deal bait, a heat pump play is sitting right in front of us, and one bootstrapped flower company is a cautionary tale with a twist.
Oil surged then slid as Iran war signals flipped overnight. The VIX jumped 14% and bond yields cratered. Here's what traders are actually doing.
Three 10% NASDAQ corrections in one year is historically a bear market signal. Except for that one time in 1999 when it then ripped 117%. No pressure.
Bitcoin is doing its best impression of a brick wall near $70K, but the real action is in altcoin chatter as geopolitical chaos rewrites the risk playbook.
The S&P 500's PEG ratio just hit a record low, lower than 2008 and COVID. So why does everything still feel terrible?
A 42% reduction in tumor recurrence should be a party. Instead, Moderna cratered 17%. Social sentiment is all over the place.
Geopolitical chaos, a VIX at 19, and 10-year yields flirting with 5%. Retail traders are still somehow bullish on Apple and Intel earnings. Bold or delusional? Let's find out.
Forget the mega-caps. While the VIX gyrates and headlines scream about Iran, three small-caps are doing actual work in niches nobody covers.
Three Mag Seven giants report earnings this week. Bloomberg's podcast crew says the $1.5T cloud backlog tells you everything you need to know.
Semis got destroyed, oil went parabolic, and Elon Musk casually suggested merging two of the world's most valuable companies. Just a normal week.
VIX up 14%, 10-year yields below 5%, oil near wartime highs. Iran headlines are doing real damage and the social sentiment data proves it.
Iran war headlines are eating the algorithm alive, but savvy YouTube channels are pivoting to Instacart and Fidelity's star fund manager. Here's what they're seeing.